Enabling discovery and innovation with 3D biology and beyond
Join Cytiva and Advanced Solutions Life Sciences for a biotech community-exclusive panel discussion around advances in 3D biology. During this webinar, we will cover topics from sample preparation to high-content analysis, highlighting how local innovators are using robotics, biofabrication, 3D imaging, and machine learning to get better answers more quickly. Our experts will also share their thoughts on the potential for continued progress in this area and discuss the importance of versatility in discovering new pathways.
Learning objectives:
• Learn how next-generation 3D bioprinting techniques can be used to automate the entire 3D assay workflow from creation, capture, and analysis
• Explore the key components that drive 3D assay robustness and the power of building more complex in vivo models
• Gain knowledge of analysis pathways and the variety of biological questions that can be addressed with 3D models
Speakers:
Jay Hoying, PhD
CSO
Advanced Solutions Life Sciences
James (Jay) Hoying, PhD is a Partner and Chief Scientist at Advanced Solutions Life Sciences. Dr. Hoying has more than 25 years of experience in basic and applied biological sciences with a focus in the microcirculation and tissue vascularization. Previously, he was the Chief of the Division of Cardiovascular Therapeutics at the Cardiovascular Innovation Institute (CII) where he developed a broad background in tissue fabrication, cell therapeutics, and translation of discoveries to industry and the clinic. Dr. Hoying is an inventor of the Angiomics microvessel technology and holds numerous patents associated with tissue vascularization and related cell-based therapies. He is one of the first to publish in the area of vascularized tissue model fabrication.
Dr. Hoying received his BA and MS degrees in Biology and Molecular Biology from Case Western Reserve University and his PhD in Cardiovascular Physiology, with an emphasis on the microcirculation, from the University of Arizona. Following this, Dr. Hoying served as a New Investigator in the National Institutes of Health Program of Excellence in Molecular Biology of the Heart and Lung (POEMB) in the Department of Molecular Genetics at the University of Cincinnati. Dr. Hoying is also a Fellow of the American Heart Association.
Michael Golway
CEO and Founder
Advanced Solutions Life Sciences
Michael Golway is an American entrepreneur, engineer and inventor. In November 2000, at the age of 31, Michael acquired his first technology company, IDS Engineering. The company had two employees with a focused business model of workflow consulting services. Today he is President and CEO of Advanced Solutions Life Sciences, which is a privately held company he acquired in November 2004, and parent company to an aggregate of technology businesses, including IDS Engineering. Michael’s passion is building and acquiring great technology companies, while growing market share through value innovation. He is the lead inventor for the integrated solution of BioAssemblyBot® and TSIM™, a 6‐Axis Robotic 3D Printing System for Human Tissue Structures. Michael has over two decades of experience leading multi-disciplined engineering, consulting and technology firms.
Derek Mathers
Director of Strategic Accounts
Advanced Solutions Life Sciences
Derek serves as Director of Strategic Accounts at Advanced Solutions Life Sciences, responsible for driving revenue growth and technological progress by forging relationships with global technology partners and technical universities. He is passionate about accelerating adoption of impactful medical technologies that interface seamlessly to biology. After graduating from University of Minnesota, he spent six years working with leading healthcare companies deploying3D printing in design, testing, and production of complex medical devices such as drug delivery devices, Deep Brain Stimulators (DBS), and orthopedic implants. Derek has previously consulted to biotech-focused venture capital firms investing in the USA, Europe, Israel, and China.
Amy Jablonski PhD
Cell Analysis Product Specialist
Cytiva
Amy Jablonski, PhD is currently a Cell Analysis Product Specialist for Cytiva, supporting all microscopy-based products. In 2014, she received a graduate degree from the Georgia Institute of Technology working on photophysical characterization of optically modulated fluorescent proteins and their novel use in imaging techniques. Driven by a passion for technical education and biology, she began work with Cytiva as an application scientist supporting microscopy customers with their research and gaining in-depth knowledge of the products. Dr. Jablonski is excited about Cytiva’s partnership with Advanced Solutions Life Sciences as she recognizes this as an opportunity to propel our customers’ science forward.